Computational mapping reveals that inhibiting mitochondrial Complex II disrupts essential purine biosynthesis in acute myeloid leukemia cells, leading to tumor regression and improved survival in preclinical models.
Most Recent Articles
Precision Immunotherapy Improves Organ Dysfunction in Phenotypically Stratified Sepsis Patients
Biomarker-guided immunotherapy targeting specific immune dysregulation patterns significantly improves organ dysfunction scores in sepsis patients compared to standard care.
Lymphocyte Kinetics as Predictors of Survival Following CAR T-Cell Infusion
Research indicates that rapid absolute lymphocyte count expansion and higher baseline levels significantly predict improved survival and response rates in non-Hodgkin lymphoma patients treated with axicabtagene ciloleucel.
Early Relapse Predicts Poor Survival and Treatment Response in nMTCL
Patients with aggressive T-cell lymphoma who relapse within 12 months face significantly worse survival outcomes but may benefit more from novel targeted therapies than standard chemotherapy.
Targeted Inhibition of Aneurysm Expansion and Vascular Calcification via Oxidation-Sensitive Polymer Delivery
Article Impact Level: HIGH Data Quality: STRONG Summary of Science Advances Dr. Wanling Liu et al. Points Researchers engineered an oxidation-sensitive polymer shell to encapsulate ultrasmall Prussian blue nanoparticles that...